Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling

被引:45
作者
Ma, Yuan [1 ,5 ]
Zou, Hai [1 ,5 ]
Zhu, Xing-Xing [2 ,5 ]
Pang, Jie [1 ,5 ]
Xu, Qiang [1 ,5 ]
Jin, Qin-Yang [1 ,5 ]
Ding, Ya-Hui [1 ,5 ]
Zhou, Bing [3 ,5 ]
Huang, Dong-Sheng [4 ,5 ]
机构
[1] Zhejiang Prov Peoples Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Prov Peoples Hosp, Dept Cardiac Surg, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Surg, Hangzhou, Zhejiang, Peoples R China
[5] Hangzhou Med Coll, Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
transforming growth factor beta; myocardial fibrosis; ventricular remodeling; mechanism; targets; SPONTANEOUSLY HYPERTENSIVE-RATS; BETA/SMAD SIGNALING PATHWAY; REGULATES CARDIAC FIBROSIS; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; HEART-FAILURE; ENDOGLIN EXPRESSION; WNT/BETA-CATENIN; AORTIC-STENOSIS; SMAD PROTEINS;
D O I
10.18632/oncotarget.17255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor beta (TGF- beta) is a multifunctional cytokine that is synthesized by many types of cells and regulates the cell cycle. Increasing evidence has led to TGF-beta receiving increased and deserved attention in recent years because it may play a potentially novel and critical role in the development and progression of myocardial fibrosis and the subsequent progress of ventricular remodeling (VR). Numerous studies have highlighted a crucial role of TGF-beta in VR and suggest potential therapeutic targets of the TGF-beta signaling pathways for VR. Changes in TGF-beta activity may elicit anti-VR activity and may serve as a novel therapeutic target for VR therapy. This review we discusses the smad-dependent signaling pathway, such as TGF-beta/Smads, TGF-beta/Sirtuins, TGF-beta/BMP, TGF-beta/miRNAs, TGF-beta/MAPK, and Smad-independent signaling pathway of TGF-beta, such as TGF-beta/PI3K/Akt, TGF-beta/Rho/ROCK, TGF-beta/Wnt/beta-catenin in the cardiac fibrosis and subsequent progression of VR. Furthermore, agonists and antagonists of TGF-beta as potential therapeutic targets in VR are also described.
引用
收藏
页码:53780 / 53790
页数:11
相关论文
共 86 条
[81]   Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis [J].
Zerr, Pawel ;
Palumbo-Zerr, Katrin ;
Huang, Jingang ;
Tomcik, Michal ;
Sumova, Barbora ;
Distler, Oliver ;
Schett, Georg ;
Distler, Joerg H. W. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :226-233
[82]   Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-β1/Smad 7 expression in the spontaneously hypertensive rats [J].
Zhai, Yuansheng ;
Gao, Xiuren ;
Wu, Qiaomei ;
Peng, Longyun ;
Lin, Jun ;
Zuo, Zhiyi .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 587 (1-3) :196-203
[83]   Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice [J].
Zhao, JS ;
Shi, W ;
Wang, YL ;
Chen, H ;
Bringas, P ;
Datto, MB ;
Frederick, JP ;
Wang, XF ;
Warburton, D .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 282 (03) :L585-L593
[84]   Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway [J].
Zhao, Xiao-Han ;
Laschinger, Carol ;
Arora, Pam ;
Szaszi, Katalin ;
Kapus, Andras ;
McCulloch, Christopher A. .
JOURNAL OF CELL SCIENCE, 2007, 120 (10) :1801-1809
[85]   MicroRNA-101a Inhibits Cardiac Fibrosis Induced by Hypoxia via Targeting TGFβRI on Cardiac Fibroblasts [J].
Zhao, Xin ;
Wang, Kejing ;
Liao, Yuhua ;
Zeng, Qiutang ;
Li, Yushu ;
Hu, Fen ;
Liu, Yuzhou ;
Meng, Kai ;
Qian, Cheng ;
Zhang, Qing ;
Guan, Hongquan ;
Feng, Kaige ;
Zhou, You ;
Du, Yimei ;
Chen, Zhijian .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (01) :213-226
[86]   Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways [J].
Zhou, Heng ;
Yang, He-Xin ;
Yuan, Yuan ;
Deng, Wei ;
Zhang, Jie-Yu ;
Bian, Zhou-Yan ;
Zong, Jing ;
Dai, Jia ;
Tang, Qi-Zhu .
JOURNAL OF MOLECULAR HISTOLOGY, 2013, 44 (03) :357-367